← Leaderboards
Christopher D Stephen
Massachusetts General Hospital
$1,098,495
Attributed
$1,098,495
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $234.4K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,098,495 · 1
By mechanism
K23$1,098,495 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Xandra Owens Breakefield$30,735,276
- David Cristopher Bragg$2,735,004
- Nutan Sharma$7,024,648
- Rosalind W Picard$1,955,895
- Paola Pedrelli$2,130,210
Others in their field
Other Emerging Leaders on “Disease Progression”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Beth Baseler · Leidos Biomedical Research, Inc.$111,936,677
- Klaus Romero · Critical Path Institute$90,404,592
- Susan Abushakra · Alzheon, Inc.$47,265,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$45,424,821
- Ryan Cirz · Revagenix, Inc.$40,209,479
Research focus
Disease ProgressionAwardDisabilityDisease PhenotypeBiochemical MarkersBiochemical ModelBioinformaticsAmericanAffectBiochemicalBloodCareer DevelopmentClinical AssessmentsClinically RelevantClinical Trial ReadinessClinical TrialsCohortBiological MarkersComplexBiologyDetectionDevelopment PlansDifferential ExpressionDystonia
Grant awards (5)
Clinical trial readiness in X-linked dystonia parkinsonism: assessment of sensor-based and blood biomarkers for early detection and monitoring disease progression$234,405
K23 · FY2025 · NS · contact PI
Clinical trial readiness in X-linked dystonia parkinsonism: assessment of sensor-based and blood biomarkers for early detection and monitoring disease progression$234,405
K23 · FY2024 · NS · contact PI
Clinical trial readiness in X-linked dystonia parkinsonism: assessment of sensor-based and blood biomarkers for early detection and monitoring disease progression$234,405
K23 · FY2023 · NS · contact PI
Clinical Trial Readiness In X-Linked Dystonia Parkinsonism: Assessment of Sensor-Based And Blood Biomarkers for Early Detection and Monitoring Disease Progression$197,640
K23 · FY2022 · NS · contact PI
Clinical trial readiness in X-linked dystonia parkinsonism: assessment of sensor-based and blood biomarkers for early detection and monitoring disease progression$197,640
K23 · FY2021 · NS · contact PI